Clinical Trials at LCMH
Little Company of Mary Hospital, in participation with SWOG, is offering a clinical trial to breast cancer patients. SWOG is a worldwide network of researchers that design and conduct cancer clinical trials. The group's goal is to change medical practice so it improves the lives of people with cancer. SWOG trials test new ways to diagnose and treat cancer, as well as prevent it. SWOG researchers also study ways to improve the care cancer patients receive, and improve quality of life for both patients and survivors.
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer. e^3 Breast Cancer Study-Evaluating Everolimus with Endocrine Therapy.
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
These are all the trials open at LCMH.
Bassel M. Atassi, MD Hematologist / Oncologist at LCMH
For more information or to learn about openings, contact:
Clinical Research Coordinator at LCMH